These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 16291356

  • 1. Transient bulging fontanelle after vaccination: case report and review of the vaccine adverse event reporting system.
    Freedman SB, Reed J, Burwen DR, Wise RP, Weiss A, Ball R.
    J Pediatr; 2005 Nov; 147(5):640-4. PubMed ID: 16291356
    [Abstract] [Full Text] [Related]

  • 2. Simultaneous vaccination of Chinese applicants for a United States immigrant visa.
    Hua L, Hongtao H, Shunqin W, Jinping G, Jiandong C, Zhaoliang L, Xinwen F.
    Travel Med Infect Dis; 2008 May; 6(3):130-6. PubMed ID: 18486068
    [Abstract] [Full Text] [Related]

  • 3. A population-based, postlicensure evaluation of the safety of a combination diphtheria, tetanus, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine in a large managed care organization.
    Zangwill KM, Eriksen E, Lee M, Lee J, Marcy SM, Friedland LR, Weston W, Howe B, Ward JI.
    Pediatrics; 2008 Dec; 122(6):e1179-85. PubMed ID: 19047220
    [Abstract] [Full Text] [Related]

  • 4. Absence of an increase in cardiorespiratory events after diphtheria-tetanus-acellular pertussis immunization in preterm infants: a randomized, multicenter study.
    Carbone T, McEntire B, Kissin D, Kelly D, Steinschneider A, Violaris K, Karamchandani N.
    Pediatrics; 2008 May; 121(5):e1085-90. PubMed ID: 18450851
    [Abstract] [Full Text] [Related]

  • 5. Immunogenicity and safety of a combination diphtheria, tetanus toxoid, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine coadministered with a 7-valent pneumococcal conjugate vaccine and a Haemophilus influenzae type b conjugate vaccine.
    Pichichero ME, Bernstein H, Blatter MM, Schuerman L, Cheuvart B, Holmes SJ, 085 Study Investigators.
    J Pediatr; 2007 Jul; 151(1):43-9, 49.e1-2. PubMed ID: 17586189
    [Abstract] [Full Text] [Related]

  • 6. Administration of tetanus, diphtheria, and acellular pertussis vaccine to parents of high-risk infants in the neonatal intensive care unit.
    Dylag AM, Shah SI.
    Pediatrics; 2008 Sep; 122(3):e550-5. PubMed ID: 18762489
    [Abstract] [Full Text] [Related]

  • 7. Immunogenicity, reactogenicity and safety of a 7-valent pneumococcal conjugate vaccine (PCV7) concurrently administered with a DTPa-HBV-IPV/Hib combination vaccine in healthy infants.
    Knuf M, Habermehl P, Cimino C, Petersen G, Schmitt HJ.
    Vaccine; 2006 May 29; 24(22):4727-36. PubMed ID: 16616973
    [Abstract] [Full Text] [Related]

  • 8. How soon after a prior tetanus-diphtheria vaccination can one give adult formulation tetanus-diphtheria-acellular pertussis vaccine?
    Halperin SA, Sweet L, Baxendale D, Neatby A, Rykers P, Smith B, Zelman M, Maus D, Lavigne P, Decker MD.
    Pediatr Infect Dis J; 2006 Mar 29; 25(3):195-200. PubMed ID: 16511379
    [Abstract] [Full Text] [Related]

  • 9. [Safety surveillance in the National Vaccination Programme; fewer adverse events with the DTP-IPV-Hib vaccine after the transition to an acellular pertussis component in 2005].
    van der Maas NA, David S, Kemmeren JM, Vermeer-de Bondt PE.
    Ned Tijdschr Geneeskd; 2007 Dec 08; 151(49):2732-7. PubMed ID: 18225797
    [Abstract] [Full Text] [Related]

  • 10. Syncope after vaccination--United States, January 2005-July 2007.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2008 May 02; 57(17):457-60. PubMed ID: 18451756
    [Abstract] [Full Text] [Related]

  • 11. Live attenuated measles and mumps viral strain-containing vaccines and hearing loss: Vaccine Adverse Event Reporting System (VAERS), United States, 1990--2003.
    Asatryan A, Pool V, Chen RT, Kohl KS, Davis RL, Iskander JK, VAERS team.
    Vaccine; 2008 Feb 26; 26(9):1166-72. PubMed ID: 18255204
    [Abstract] [Full Text] [Related]

  • 12. Comparison of adverse effects following immunization with vaccine containing whole-cell vs. acellular pertussis components.
    Zieliński A, Rosińska M.
    Przegl Epidemiol; 2008 Feb 26; 62(3):589-96. PubMed ID: 19108523
    [Abstract] [Full Text] [Related]

  • 13. Polyarteritis nodosa reports to the vaccine adverse event reporting system (VAERS): implications for assessment of suspected vaccine-provoked vasculitis.
    Begier EM, Langford CA, Sneller MC, Wise RP, Ball R, VAERS Working Group.
    J Rheumatol; 2004 Nov 26; 31(11):2181-8. PubMed ID: 15517631
    [Abstract] [Full Text] [Related]

  • 14. Prospective assessment of the effect of needle length and injection site on the risk of local reactions to the fifth diphtheria-tetanus-acellular pertussis vaccination.
    Jackson LA, Starkovich P, Dunstan M, Yu O, Nelson J, Dunn J, Rees T, Zavitkovsky A, Maus D, Froeschle JE, Decker M.
    Pediatrics; 2008 Mar 26; 121(3):e646-52. PubMed ID: 18310184
    [Abstract] [Full Text] [Related]

  • 15. Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine.
    America Academy of Pediatrics Commitee on Infectious Diseases.
    Pediatrics; 2006 Mar 26; 117(3):965-78. PubMed ID: 16382131
    [Abstract] [Full Text] [Related]

  • 16. Thrombocytopenia after vaccination: case reports to the US Vaccine Adverse Event Reporting System, 1990-2008.
    Woo EJ, Wise RP, Menschik D, Shadomy SV, Iskander J, Beeler J, Varricchio F, Ball R.
    Vaccine; 2011 Feb 01; 29(6):1319-23. PubMed ID: 21126606
    [Abstract] [Full Text] [Related]

  • 17. The impact of DTaP-IPV-HB vaccine on use of health services for young infants.
    Thompson LA, Irigoyen M, Matiz LA, LaRussa PS, Chen S, Chimkin F.
    Pediatr Infect Dis J; 2006 Sep 01; 25(9):826-31. PubMed ID: 16940842
    [Abstract] [Full Text] [Related]

  • 18. Elective termination of pregnancy after vaccination reported to the Vaccine Adverse Event Reporting System (VAERS): 1990-2006.
    Chang S, Ball R, Braun MM.
    Vaccine; 2008 May 02; 26(19):2428-32. PubMed ID: 18406499
    [Abstract] [Full Text] [Related]

  • 19. Safety of reduced-antigen-content tetanus-diphtheria-acellular pertussis vaccine in adolescents as a sixth consecutive dose of acellular pertussis-containing vaccine.
    Zepp F, Knuf M, Habermehl P, Mannhardt-Laakmann W, Howe B, Friedland LR.
    J Pediatr; 2006 Nov 02; 149(5):603-610. PubMed ID: 17095328
    [Abstract] [Full Text] [Related]

  • 20. Vaccination of yeast sensitive individuals: review of safety data in the US vaccine adverse event reporting system (VAERS).
    DiMiceli L, Pool V, Kelso JM, Shadomy SV, Iskander J, V.A.E.R.S. Team.
    Vaccine; 2006 Feb 06; 24(6):703-7. PubMed ID: 16154669
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.